Trials

Trial Name Statussort descending
NC002
NC002 Phase II Trial to Evaluate the Efficacy, Safety and Tolerability of the Following: PA-824 Plus Moxifloxacin Plus Pyrazinamide in Drug Sensitive and Multi-Drug Resistant Patients
Phase 2a Study of PBTZ169
NC001 submitted for publication
NC001 Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) submitted for publication
TBTC Study 30: A Phase I/II Pilot Study for Evaluation of Low Dose, Once Daily, Linezolid Plus Optimized Background Therapy (OBT) Versus Placebo Plus OBT for the Treatment of Multi-drug Resistant Tube submitted for publication
TBTC Study 30PK Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis submitted for publication
Perchlozone tablets submitted for publication
Traitement du Sida submitted for publication
Faro-WBA submitted for publication
endTB-Q: "Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance" enrolling
Pediatric PK and Safety Trial Delamanid in MDR TB enrolling
Phase 2 Placebo-controlled, Randomized Study of Oral Immunomodulator in TB and TB/HIV Patients enrolling
ACTG 5343 Bedaquiline - Delamanid with MBT for MDR enrolling
RIFASHORT enrolling
Phase 1 Safety, Tolerability, and Pharmacokinetics of SPR720 enrolling
NexGen EBA enrolling
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults enrolling
BEAT-TB Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis enrolling
NC003 enrolling
EBA, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis enrolling
NC005 enrolling
Phase 1 Safety, Tolerability and Pharmacokinetics of BVL-GSK098 enrolling
NC003 Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) enrolling
PredictTB enrolling
Phase 1 Safety, Tolerability and Pharmacokinetics of GSK2556286 enrolling
Phase 2: IMPACT-TB Safety, Pharmacokinetics & Hematologic Effect of Imatinib enrolling
TBTC Study 32, Opti-Q enrolling
ACTG 5306 Phase I Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin enrolling
A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients enrolling
Phase 2. Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis enrolling
Safety and efficacy of blocking IL-4 with pascolizumab in patients receiving standard combination therapy for pulmonary tuberculosis (TB): a randomized, double-blind, placebo-controlled, proof-of-conc enrolling
A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial of LCB01-0371. enrolling
Phase 2. Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis enrolling
ACTG 5306 Phase I, Three-Arm Safety, Tolerability, and Pharmacokinetic Interaction Study of PA-824, an Investigational Nitroimidazole for the Treatment of Tuberculosis, Together With Efavirenz, Ritona enrolling
TBI-223 Phase 1 MAD enrolling
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis. all patients enrolled
TBA-354 Phase 1a Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects all patients enrolled
Controlled comparison of two moxifloxacin containing treatment shortening regimens with the standard regimen in pulmonary TB all patients enrolled
STAND all patients enrolled
TBTC Study 31 ACTG 5349 4-month treatment regimens all patients enrolled
ZeNix (B-Pa-L) NC-007 all patients enrolled
PanACEA-MAMS-TB-01 all patients enrolled
Sutezolid Dose-finding and Combination Evaluation (SUDOCU) all patients enrolled
DECODE- Delpazolid Dose-Finding and Combination Development Trial all patients enrolled
Nix-TB (B-Pa-L) all patients enrolled
Q203 Phase 1b Q203-TB-PI-US002 all patients enrolled
Nitzoxanide NZT001 14-day EBA all patients enrolled
SimpliciTB all patients enrolled
endTB all patients enrolled
A Phase IIa, Open Label Study to Determine the EBA, Extended EBA and Pharmacokinetic Study of LL3858 for the Treatment of Newly Diagnosed Sputum Smear-Positive Pulmonary TB study in development
BTZ-043 Multiple Ascending Dose / EBA study in development
SimpliciTB-Pa-M-Z) NC-008 study in development
Phase 2b/c. 4-month Regimen of OPC-167832, Delamanid and Bedaquiline for DS Pulmonary TB study in development
TMC207-TBC211 study in development
B1171001 published
AZD5847 Randomized, Open Label, Multiple Dose Phase 2a Study of the Early Bactericidal Activity of AZD5847 in Adults With Pulmonary Tuberculosis published
B1171002 published
B1171003 published
PanACEA-MAMS-TB-01 published
LMU-IMPH-SQ109-01 published
Rifapentine TBTC Study 29 published
SQ109-CP001 published
Phase 2 Safety, Efficacy & Biomarker Response of HDTs Added to Standard Therapy published
09-0111 N01AI80024C published
TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection published
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis published
High-Dose Rifampin published
NIH: A Phase I Open-Label Trial To Investigate the Pharmacokinetic Interaction Between Rifabutin Or Rifampin And A Single Dose Of TMC207 In Healthy Subjects published
Phase 2 Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis published
TMC207-TiDP13-208 published
PanACEA - RUNMC - HR1 2007.23011.01 published
TMC207-TiDP13-C209 published
NC-003 published
Meropenem, Faropenem Phase 2 EBA, TASK-001 published
Phase 2 Telacebec (Q203) EBA published
TMC207TBC1002 published
242-07-204 published
Single Dose, Phase 1 published
Multiple Dose, Phase 1 published
NC-005 published
OPC-167832 Phase 1 / 2 EBA in data analysis
Celecoxib Clinical Study WBA in data analysis
TB-PRACTECAL in data analysis
ReDEFINe High-Dose RIF for Meningitis in data analysis
TBTC Study 33/iAdhere: AdherenceC in data analysis
Phase 2b: StAT-TB (Statin Adjunctive Therapy for TB) in data analysis
TRUNCATE-TB in data analysis
Phase 1 Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers in data analysis
STREAM Trial Stage 2 in data analysis
Q203 Phase 1a Q203-TB-PI-US001 in data analysis
Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 in data analysis
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis in data analysis
Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers in data analysis
Delamanid with OBR for MDR TB in data analysis
NExT Trial: Bedaquiline - Linezolid with OBR MDR early termination
TBA 354 Phase 1b Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects early termination